Did You Invest in the Royal Bank of Scotland’s Callable Range Accrual Notes Linked to the Difference between CMS30 and CMS2 due November 30, 2026 (CUSIP: 78009PBE0)?
According to RBS’s prospectus on CUSIP: 78009PBE0:
Your return on the securities with respect to any interest period in which the interest rate is linked to the difference between CMS30 and CMS2 will be limited by the “base rate” applicable to the relevant quarterly interest period; in no event will the interest rate applicable to your securities be greater than the applicable base rate regardless of the difference between CMS30 and CMS2 on any given day.
Investors ought to be cautious with this type of investment. According to the Financial Industry Regulatory Authority (FINRA):
If you bought the structured product known as Royal Bank of Scotland’s Callable Range Accrual Notes Linked to the Difference between CMS30 and CMS2 due November 30, 2026 CUSIP: 78009PBE0, and it was sold to you as a safe, liquid, and/or conservative investment, and then you suffered losses, you may have a claim. Contact the attorneys at Sonn Law Group for free consultation.
Image credit: Elliott Brown via Flickr